Raf-independent and MEKK1-dependent activation of NF-κB by hydrogen peroxide in 70Z/3 pre-B lymphocyte tumor cells

Journal of Cellular Biochemistry

Volumn 88, Issue 3, 2003, Pages 545-556

  Lee, Michael ^a   Koh, Woo Suk ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Hydrogen peroxide; I B kinase; MEKK1; NF B; Raf

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; RAF PROTEIN; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PHOSPHORYLATION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; ENZYME ACTIVATION; ENZYME INHIBITORS; HYDROGEN PEROXIDE; I-KAPPA B PROTEINS; MAP KINASE KINASE KINASE 1; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXIDANTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-RAF;

MURINAE;

EID: 0037441525     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10376     Document Type: Article

References (49)

1. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG. 1997. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptormediated tyrosine phosphorylation. J Biol Chem 272:217-221.
2. Bagowski CP, Xiong W, Ferrell JE. 2001. c-Jun N-terminal kinase activation in Xenopus laevis eggs and embryos. A possible non-genomic role for the JNK signaling pathway. J Biol Chem 276:1459-1465.
3. Baldwin JAS. 1996. The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 14:649-683.
4. Birkenkamp KU, Tuyt LML, Lummen C, Wierenga ATJ, Kruijer W, Vellenga E. 2000. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway. Br J Pharmacol 131:99-107.
5. Bowie A, O'Neill LAJ. 2000. Oxidative stress and nuclear factor-κB activation. Biochem Pharmacol 59:13-23.
6. Chang L, Karin M. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37-40.
7. Chen S-Y, Huff SY, Lai C-C, Der CJ, Powers S. 1994. RasG15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor. Oncogene 9:2691-2698.
8. Deak JC, Templeton DJ. 1997. Regulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domain. Biochem J 322:185-192.
9. Dent P, Haser W, Haystead TAJ, Vincent LA, Roberts TM, Sturgill TW. 1992. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257:1404-1407.
10. Dumont A, Hehner SP, Hofmann TG, Ueffing M, Droge W, Schmitz ML. 1999. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB. Oncogene 18:747-757.
11. El-Hag A, Lipsky PE, Bennett M, Clark RA. 1986. Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: Differential susceptibility of human lymphocyte functions. J Immunol 136:3420-3426.
12. Finkel T. 1998. Oxygen radicals and signaling. Curr Opin Cell Biol 10:248-253.
13. Flohe L, Brigelius-Flohe R, Saliou C, Traber MG, Packer L. 1997. Redox regulation of NF-κB activation. Free Radic Biol Med 22:1115-1126.
14. Flory E, Weber CK, Chen P, Hoffmeyer A, Jassoy C, Rapp UR. 1998. Plasma membrane-targeted Raf kinase activates NF-κB and human immunodeficiency virus type 1 replication in T lymphocytes. J Virol 72:2788-2794.
15. Gardner AM, Vaillancourt RR, Lange-Carter CA, Johnson GL. 1994. MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: Analysis of phosphopeptides and regulation of activity. Mol Cell Biol 5:193-201.
16. Ghosh S, May MJ, Kopp EB. 1998. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260.
17. 2. Role in cell survival following oxidant injury. J Biol Chem 271:4138-4142.
18. Hagemann D, Tropmair J, Rapp UR. 1999. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells. Oncogene 18:1391-1400.
19. Hambleton J, McMahon M, DeFranco AL. 1995. Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharideinduced signaling events. J Exp Med 182:147-154.
20. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF. 1996. Tyrosine phosphorylation of IκBα activates NFκB without proteolytic degradation of IκBα. Cell 86:787-798.
21. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ. 1997. Mitogenic signaling mediated by oxidants in Rastransformed fibroblasts. Science 275:1649-1652.
22. Israel A. 2000. The IKK complex: An integrator of all signals that activate NF-κB? Trends Cell Biol 10:129-133.
23. Janssen-Heininger YNW, Macara I, Mossman BT. 1999. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-κB: Requirement of Ras/mitogen-activated protein kinases in the activation of NF-κB by oxidants. Am J Respir Cell Mol Biol 20:942-952.
24. Jaspers I, Zhang W, Fraser A, Samet JM, Reed W. 2001. Hydrogen peroxide has opposing effects on IKK activity and IκBα breakdown in airway epithelial cells. Am J Respir Cell Mol Biol 24:769-777.
25. Karandikar M, Xu S, Cobb MH. 2000. MEKK1 binds Raf-1 and the ERK2 cascade components. J Biol Chem 275:40120-40127.
26. Karin M. 1999. The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 274:27339-27342.
27. Kaul N, Gopalakrishna R, Gundimeda U, Choi J, Forman HJ. 1998. Role of protein kinase C in basal and hydrogen peroxide -stimulated NF-κB activation in the murine macrophage J774A.1 cell line. Arch Biochem Biophys 350:79-86.
28. Kyriakis JM, App H, Zhang X-F, Banerjee P, Brautigan DL, Rapp UR, Avruch J. 1992. Raf-1 activates MAP kinasekinase. Nature 358:417-421.
29. Lallena M-J, Diaz-Meco MT, Bren G, Paya CV, Moscat J. 1999. Activation of IκB kinase β by protein kinase C isoforms. Mol Cell Biol 19:2180-2188.
30. Lander HM, Ogiste JS, Teng KK, Novogrodsky A. 1995. p21ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem 270:21195-21198.
31. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL. 1993. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260:315-319.
32. Lee M, Jeon YJ. 2001. Paclitaxel-induced immune suppression is associated with NF-κB activation via conventional PKC isotypes in lipopolysaccharide-stimulated 70Z/3 preB lymphocyte tumor cells. Mol Pharmacol 59:248-253.
33. Lee M, Yang KH. 2000. 2-acetylaminofluorene suppresses immune response through the inhibition of nuclear factor-κB activation during the early stage of B cell development. Toxicol Lett 114:173-180.
34. Lee M, Yea SS. 2000. Hydrogen peroxide inhibits the immune response to lipopolysaccharide by attenuating signaling through c-Jun N-terminal kinase and p38 associated with protein kinase C. Immunopharmacology 48:165-172.
35. Lee FS, Hagler J, Zhijian J, Chen ZJ, Maniatis T. 1997. Activation of the IκB kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88:213-222.
36. Lin B, Williams-Skipp C, Tao Y, Schleicher MS, Cano LL, Duke RC, Scheinman RI. 1999. NF-κB functions a both a pro-apoptotic and anti-apoptotic regulatory factor within a single cell type. Cell Death Differ 6:570-582.
37. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719-1723.
38. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, Okumura K. 1998. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κBinducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA 95:3537-3542.
39. Olah Z, Ferrier A, Lehel C, Anderson WB. 1995. The 33-kDa C-terminal domain of Raf-1 protein kinase exhibits a Ras-independent serum- and phorbol ester-induced shift in gel mobility. Biochem Biophys Res Commun 214:340-347.
40. Pahan K, Liu X, McKinney MJ, Wood C, Sheikh FG, Raymond JR. 2000. Expression of a dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-κB in primary astrocytes. J Neurochem 74:2288-2295.
41. Rice NR, Ernst MK. 1993. In vivo control of NF-κB activation by IκB-α. EMBO J 12:4685-4695.
42. Romerio F, Riva A, Zella D. 2000. Interferone-α2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism. Br J Cancer 83:532-538.
43. Rosa LF. 1997. Effect of adrenaline on lymphocyte metabolism and function. A mechanism involving cAMP and hydrogen peroxide. Cell Biochem Funct 15:103-112.
44. 2 for platelet-derived growth factor signal transduction. Science 270:296-299.
45. 2 and TNF-α and its effects on ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 279:L302-L311.
46. Trushin SA, Pennington KN, Algeciras-Schimnich A, Paya CV. 1999. Protein kinase C and calcineurin synergize to activate IκB kinase and NF-κB in T lymphocytes. J Biol Chem 274:22923-22931.
47. Tuyt LML, Dokter WHA, Birkenkamp K, Koopmans SB, Lummen C, Kruijer W, Vellenga E. 1999. Extracellularregulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-κB-dependent IL-6 expression in human monocytes. J Immunol 162:4893-4902.
48. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. 1997. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK, Science 278:866-870.
49. Yujiri T, Sather S, Fanger GR, Johnson GL. 1998. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science 282:1911-1914.